What's breaking now, across thousands of outlets.
The study found a two-dose treatment achieved 95.3% efficacy, with all 168 dogs surviving compared with a more intensive three-dose treatment
We haven't written up this one. Toronto Sun has the full story — the link below goes straight to it.
Newly developed biomarkers may enhance clinicians' ability to detect and treat disorders of the nervous system, including Alzheimer's disease, mood disorders and neurodevelopmental conditions.
New evidence supports the idea that differences within and between sexes impact how neurological disorders progress and respond to treatment.
Research on Alzheimer's disease (AD) and aging has found strong connections between physical health and brain health. These new connections were presented at Neuroscience 2026, the annual meeting of…
Exclusive: 2,850 more patients a month would need to be treated within 62 days to meet March 2027 goal, as experts warn of failure of leadership Nearly 10,000 more cancer patients in England will not be treated on time because the government will fail to meet its targets, amid a failure of leadership, focus and resource, experts have…
Humiliation can leave memories that are hard to shake. A new study suggests that people who have felt humiliated tend to be less happy, and that repetitive negative thinking may be part of the reason.
A controversial change to "safer-supply" opioid prescriptions in Ontario that would force recipients to take them in front of a pharmacist, rather than on their own schedule at home, has been abruptly paused due to a legal challenge.
